3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Churchill Livingstone
Abstract
Description
Keywords
Antineoplastic agents, Breast neoplasms, Consensus development conferences as topic, Female, Humans, Palliative care, Receptor, erbb-2, Receptors, estrogen, Triple negative breast neoplasms, Lapatinib, Palbociclib, Pertuzumab, Trastuzumab, Vinorelbine tartrate, Antineoplastic agent, Epidermal growth factor receptor 2, Erbb2 protein, human, Estrogen receptor, Article, Breast cancer, Cancer chemotherapy, Cancer classification, Cancer surgery, Cancer survival, Drug approval, Drug efficacy, Estrogen receptor positive breast cancer, Her2 negative advanced breast cancer, Her2 positive advanced breast cancer, Human, Methodology, Overall survival, Palliative therapy, Patient care, Patient education, Phase 2 clinical trial (topic), Phase 3 clinical trial (topic), Practice guideline, Priority journal, Quality of life, Randomized controlled trial (topic), Supportive care, Triple negative breast cancer, Chemistry, Consensus development, Pathology